CIC
AERI

Chilton Investment Company’s Aerie Pharmaceuticals AERI Stock Holding History

Chilton Investment Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-36,381
Closed -$537K – 154
2020
Q2 		$537K Sell
36,381
-7,003
-16% -$104K 0.02% 109
2020
Q1 		$586K Sell
43,384
-23,493
-35% -$446K 0.02% 87
2019
Q4 		$1.62M Buy
66,877
+17,995
+37% +$373K 0.05% 75
2019
Q3 		$940K Buy
+48,882
New +$1.12M 0.03% 81

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Chilton Investment Company's AERI Position: Q3 2020 in Review

Chilton Investment Company sold out of Aerie Pharmaceuticals (AERI) in Q3 2020, closing a stake of 36,381 shares — an estimated $537K sold.

Chilton Investment Company first reported a position in AERI in Q3 2019 and held it in 4 quarters. The position peaked at $1.62M in Q4 2019. 148 funds tracked by Wall St. Rank hold AERI as of Q3 2020.

  • Chilton Investment Company reported no remaining Aerie Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Chilton Investment Company sold 36,381 Aerie Pharmaceuticals shares in Q3 2020, an estimated $537K.
  • Chilton Investment Company first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Chilton Investment Company's Aerie Pharmaceuticals position peaked at $1.62M in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2020.

Based on Chilton Investment Company's 13F filing for Q3 2020, filed 9 Nov 2020.